Home blood tests and transfusions for new AML patients
Part of Blood & lymphatic, Cancer clinical trials.
This trial tests whether people with newly diagnosed AML can safely check their own blood counts at home and receive transfusions there while getting chemotherapy at home. If it works, you may need fewer hospital visits.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older
- You were diagnosed with acute myeloid leukemia (AML) in the last 4 weeks
- Your doctor plans to give you chemotherapy at home
- You can understand and speak Danish
- You are able to check your own blood counts at home and get transfusions there
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a special immune cell infusion (NK cells) from a half-matched family donor can help keep your AML in remission after initial chemotherapy. It is meant for people who have recently achieved their first remission and are otherwise healthy enough for a second round of chemo.
This study tests whether cancer patients can do their own blood counts at home using a finger-prick test. It will help see if home monitoring is a good option for people receiving chemotherapy.
This trial tests whether it is safe to give blood transfusions at home instead of in the hospital. It is for people who need regular blood transfusions for their cancer care.
This study looks at how blood counts and clotting change in adults newly diagnosed with acute myeloid leukemia (AML) who receive a strong type of chemotherapy. It aims to better understand how to manage these patients during treatment.
This study is for adults with acute myeloid leukemia (AML) whose cancer has returned or is not responding to treatment. Researchers will analyze your leukemia cells to learn more about the disease and possibly find better treatments.
This study looks at whether a simple blood test can help track how well treatment is working in children with leukemia. It may help doctors understand the disease better and guide future care.
Hear when a new Acute Myeloid Leukaemia (AML) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.